cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Sutro Biopharma Inc
1 own
5 watching
Current Price
$7.49
$-0.26
(-3.35%)
logo-stro
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
409.19M
52-Week High
52-Week High
10.78
52-Week Low
52-Week Low
3.33
Average Volume
Average Volume
0.25M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization409.19M
icon52-Week High10.78
icon52-Week Low3.33
iconAverage Volume0.25M
iconDividend Yield--
iconP/E Ratio--
What does the Sutro Biopharma Inc do?
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company s product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.
Read More
How much money does Sutro Biopharma Inc make?
News & Events about Sutro Biopharma Inc.
Ticker Report
15days ago
Sutro Biopharma (NASDAQ:STRO Get Rating) had its price objective lifted by research analysts at Piper Sandler from $16.00 to $18.00 in a research report issued to clients and investors on Tuesday, The Fly reports. The brokerage presently has an overweight rating on the stock. ...
Globe Newswire
23days ago
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will ...
Globe Newswire
1month ago
- Conference call and webcast to be held on Monday, January 9, 2023 at 1:30 pm PT, or 4:30 pm ET - SOUTH SAN FRANCISCO, Calif., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format ...
Globe Newswire
1month ago
- A total of 17 pediatric patients were treated with STRO-002 on a compassionate use basis; eight patients achieved complete remission, of which seven patients were MRD negative - - Safety and efficacy profile in this patient population provides added confidence to advance clinical development of ...
Globe Newswire
2 months ago
SOUTH SAN FRANCISCO, Calif., Nov. 23, 2022 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs), today announced that Bill Newell, Chief Executive Officer, will ...
Frequently Asked Questions
Frequently Asked Questions
What is Sutro Biopharma Inc share price today?
plus_minus_icon
Can Indians buy Sutro Biopharma Inc shares?
plus_minus_icon
How can I buy Sutro Biopharma Inc shares from India?
plus_minus_icon
Can Fractional shares of Sutro Biopharma Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Sutro Biopharma Inc stocks?
plus_minus_icon
What is today’s traded volume of Sutro Biopharma Inc?
plus_minus_icon
What is today’s market capitalisation of Sutro Biopharma Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Sutro Biopharma Inc?
plus_minus_icon
What percentage is Sutro Biopharma Inc down from its 52-Week High?
plus_minus_icon
What percentage is Sutro Biopharma Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$7.49
$-0.26
(-3.35%)
logo-stro
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00